Richard Shelby actually said...

"As research becomes more expensive and private capital dries up, I believe it's critical to ensure support for translational research."

"I believe the need for an entity to straddle the world's research and industry is clear."

"It seems like that's an ideal opportunity for academia to team with industry to bring treatments to patients faster."

"Oh, quite intensively."